MOH
Get informed when a big investor buys or sells
+ FollowUndervalued by 376.4% based on the discounted cash flow analysis.
| Market cap | $9.04 Billion |
|---|---|
| Enterprise Value | $8.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $8.93 |
| Beta | 0.85 |
| Outstanding Shares | 51,000,000 |
| P/E Ratio | 47.09 |
|---|---|
| PEG | -49.42 |
| Price to Sales | 0.17 |
| Price to Book Ratio | 2.31 |
| Enterprise Value to Revenue | 0.15 |
| Enterprise Value to EBIT | 18.74 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 1.07 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.0462▲ 67.38% |
|---|---|
| Total Calls | 551,700▼ 20.82% |
| Total Puts | 1,128,900▲ 18.05% |
Holdings and activity of institutional investors.
| Ownership % | 108.55%▲ 9.26% |
|---|---|
| Total Invested | $7.35B▼ 20.18% |
| Investors Holding | 547▼ 32.00% |
No data
This is one of the most powerful committees for Molina Healthcare, as it controls taxation, trade, and crucial entitlement spending, including Medicare and Medicaid. It influences corporate valuations through tax policy and directly impacts healthcare pricing and funding, which are central to Molina's business.
This committee directly allocates discretionary federal spending. Its subcommittees determine the precise funding levels for federal healthcare programs (e.g., Medicaid, Medicare) from which Molina Healthcare derives a substantial portion of its revenue. Its decisions have a direct and immediate impact on Molina's financial prospects.
This committee regulates key federal health agencies like the FDA and NIH, which influence drug approvals and costs (a major component of insurance payouts). It also impacts labor laws, affecting Molina Healthcare's workforce and its network of healthcare providers. Its influence on the broader healthcare ecosystem is direct and significant.
Molina Healthcare is a significant provider of Medicare Advantage plans for older Americans. This committee's investigations and hearings on drug pricing and long-term care quality directly impact the costs, services, and public perception of programs critical to Molina's business.
This committee drafts the budget resolution that sets spending ceilings for federal programs, including crucial healthcare entitlements like Medicare and Medicaid. These programs are fundamental to Molina Healthcare's business model and revenue streams, making its influence direct and significant.